Prevalence and nondisclosure of complementary and alternative medicine use in patients with cancer and cancer survivors in the United States
JAMA Oncology May 08, 2019
Sanford NN, et al. - In this cross-sectional study, researchers used data from a comprehensive nationwide survey to determine the use of complementary and alternative medicine (CAM), as well as the associated rates of nondisclosure among patients with cancer and cancer survivors in the United States. In all, worse survival was observed in a small subset of patients who reported CAM use (n=258; 0.01% of the study population) vs patients who did not use CAM, and refusal of conventional cancer therapy seemed to mediate this finding. Overall, the investigators concluded that there is a need for an accurate evaluation of the prevalence of CAM use because CAM use has potentially serious, adverse, and wide-reaching implications in patients with cancer.
55 lakhs+ doctors trust M3 globally
Unlimited access to original articles by experts
Secure: we never sell your data
Signing up takes less than 2 mins